Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Moodys
Boehringer Ingelheim
Baxter
Dow

Last Updated: January 21, 2020

DrugPatentWatch Database Preview

Drug Price Trends for CRIXIVAN

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Best Wholesale Price for CRIXIVAN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
CRIXIVAN 200MG CAP Merck Sharp & Dohme Corporation 00006-0571-43 360UU 449.05 1.24736 EACH 2019-01-01 - 2023-08-31 FSS
CRIXIVAN 200MG CAP Merck Sharp & Dohme Corporation 00006-0571-43 360UU 337.19 0.93664 EACH 2020-01-01 - 2023-08-31 Big4
CRIXIVAN 200MG CAP Merck Sharp & Dohme Corporation 00006-0571-43 360UU 449.05 1.24736 EACH 2020-01-01 - 2023-08-31 FSS
CRIXIVAN 400MG CAP Merck Sharp & Dohme Corporation 00006-0573-62 180UU 337.54 1.87522 EACH 2018-09-01 - 2023-08-31 Big4
CRIXIVAN 400MG CAP Merck Sharp & Dohme Corporation 00006-0573-62 180UU 449.06 2.49478 EACH 2018-09-01 - 2023-08-31 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type

Subscribe to access the full database, or Start Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Boehringer Ingelheim
Moodys
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
Copyright 2002-2020 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2020 - 2021
 NCE-1 Patent Challenge Dates 2020 - 2021
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2020, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

DrugPatentWatch reviews